TNF-α, IL-6, and IL-8 Cytokines and Their Association with TNF-α-308 G/A Polymorphism and Postoperative Sepsis

Journal of Gastrointestinal Surgery

Volumn 18, Issue 8, 2014, Pages 1486-1494

  Baghel, Kavita ^a   Srivastava, Rajeshwar Nath ^a   Chandra, Abhijit ^a   Goel, Sudhir K ^b   Agrawal, Jyotsna ^a   Kazmi, Hasan Raza ^a   Raj, Saloni ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cytokines; Genetic polymorphism; Restriction fragment length polymorphism; Sepsis; Tumor necrosis factor

Indexed keywords

BIOLOGICAL MARKER; GENETIC MARKER; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RISK; RISK FACTOR; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RISK FACTORS; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84904258760     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-014-2574-5     Document Type: Article

References (40)

1. Faist E, Wichmann M, Kim C: Immunosuppression and immunomodulation in surgical patients. Curr Opin Crit Care 1997;3: 293-298.
2. Beutler B, Grau GE: Tumor Necrosis Factor in the pathogenesis of infectious diseases. Crit Care Med 1993;21: S423-435.
3. Bazzoni F, Beutler B: The Tumor Necrosis Factor ligand and receptor families. N Engl J Med 1996;334: 1717-1725.
4. Wheeler AP, Bernard GR: Treating patients with severe sepsis. N Engl J Med 1999;340: 207-214.
5. Debets JM, Kampmeijer R, van der Linden MP, Buurman WA, van der Linden CJ: Plasma Tumor Necrosis Factor and mortality in critically ill septic patients. Crit Care Med 1989;17: 489-494.
6. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP: Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349: 170-173.
7. Rink L, Kirchner H: Recent progress in the tumor necrosis factor-alpha field. Int Arch Allergy Immunol 1996;111: 199-209.
8. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW: An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993;177: 557-560.
9. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul JL, Riché F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut JF: Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999;282: 561-568.
10. Appoloni O, Dupont E, Vandercruys M, Andriens M, Duchateau J, Vincent JL: Association of tumor necrosis factor-2 allele with plasma tumor necrosis factor-alpha levels and mortality from septic shock. Am J Med 2001;110: 486-488.
11. Stuber F, Udalova IA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, Schade FU, Nedospasov SA: -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1996;46: 42-50.
12. O'Keefe GE, Hybki DL, Munford RS: The G-->A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma 2002;52: 817-825.
13. Tang GJ, Huang SL, Yien HW, Chen WS, Chi CW, Wu CW, Lui WY, Chiu JH, Lee TY: Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000;28: 2733-2736.
14. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S Mahieu P, Malaise M, De Groote D, Louis R, Belaiche J: Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998;113: 401-406.
15. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;94: 3195-3199.
16. Kothari N, Bogra J, Abbas H, Kohli M, Malik A, Kothari D, Srivastava S, Singh PK: Tumor necrosis factor gene polymorphism results in high TNF level in sepsis and septic shock. Cytokine 2013;61: 676-681.
17. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL: Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 1996;46: 32-41.
18. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101: 1644-1655.
19. Allen RA, Lee EM, Roberts DH, Park BK, Pirmohamed M: Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease. Eur J Clin Invest 2001;31: 843-851.
20. Majetschak M, Flohe S, Obertacke U, Schroder J, Staubach K, Nast-Kolb D, Schade FU, Stuber F: Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 1999;230: 207-214.
21. Duan ZX, Gu W, Zhang LY, Jiang DP, Zhou J, Du DY, Zen L, Chen KH, Liu Q, Jiang JX: Tumor necrosis factor alpha gene polymorphism is associated with the outcome of trauma patients in Chinese Han population. J Trauma 2011;70: 954-958.
22. Bittar MN, Carey JA, Barnard JB, Pravica V, Deiraniya AK, Yonan N, Hutchinson IV: Tumor necrosis factor alpha influences the inflammatory response after coronary surgery. Ann Thorac Surg 2006;81: 132-137.
23. Majetschak M, Obertacke U, Schade FU, Bardenheuer M, Voggenreiter G, Bloemeke B, Heesen M: Tumor necrosis factor gene polymorphisms, leukocyte function, and sepsis susceptibility in blunt trauma patients. Clin Diagn Lab Immunol 2002;9: 1205-1211.
24. Read RC, Teare DM, Pridmore AC, Naylor SC, Timms JM, Kaczmarski EB, Borrow R, Wilson AG: The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality. Crit Care Med 2009;37: 1237-1243.
25. Strey CW, Marquez-Pinilla RM, Markiewski MM, Siegmund B, Oppermann E, John Lambris JD, Bechstein WO: Early post-operative measurement of cytokine plasma levels combined with pre-operative bilirubin levels identify high-risk patients after liver resection. Int J Mol Med 2011;27: 447-454.
26. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990;87: 1233-1237.
27. Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack van Schijndel RJ, Eerenberg-Belmer AJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 1989;74: 1704-1710.
28. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992;215: 356-362.
29. Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA: Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992;60: 2835-2842.
30. Giannoudis PV, Smith MR, Evans RT, Bellamy MC, Guillou PJ: Serum CRP and IL-6 levels after trauma. Not predictive of septic complications in 31 patients. Acta Orthop Scand 1998;69: 184-188.
31. Majetschak M, Krehmeier U, Ostroverkh L, Blömeke B, Schäfer M: Alterations in leukocyte function following surgical trauma: differentiation of distinct reaction types and association with tumor necrosis factor gene polymorphisms. Clin Diagn Lab Immunol 2005;12: 296-303.
32. Tang R, Chen HH, Wang YL, Changchien CR, Chen JS, Hsu KC, Chiang JM, Wang JY: Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2, 809 consecutive patients. Ann Surg 2001;234: 181-189.
33. Offner PJ, Moore EE, Biffl WL: Male gender is a risk factor for major infections after surgery. Arch Surg 1999;134: 935-940.
34. Velasco E, Thuler LC, Martins CA, Dias LM, Conalves VM: Risk factors for infectious complications after abdominal surgery for malignant disease. Am J Infect Control 1996;24: 1-6.
35. Schröder J, Kahlke V, Staubach KH, Zabel P, Stüber F: Gender differences in human sepsis. Arch Surg 1998;133: 1200-1205.
36. Eachempati SR, Hydo L, Barie PS: Gender-based differences in outcome in patients with sepsis. Arch Surg 1999;134: 1342-1347.
37. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW: Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 2000;26: 167-172.
38. Ansari MZ, Collopy BT, Hart WG, Carson NJ, Chandraraj EJ: In-hospital mortality and associated complications after bowel surgery in Victorian public hospitals. Aust N Z J Surg 2000;70: 6-10.
39. Vogel TR, Dombrovskiy VY, Carson JL, Graham AM, Lowry SF: Postoperative sepsis in the United States. Ann Surg 2010;252: 1065-1071.
40. Hensler T, Heidecke CD, Hecker H, Heeg K, Bartels H, Zantl N, Wagner H, Siewert JR, Holzmann B: Increased Susceptibility to Postoperative Sepsis in Patients with Impaired Monocyte IL-12 Production. J Immunol 1998;161: 2655-2659.